by  Ruhr-Universitaet-Bochum

In the majority of cases, dementia can be traced back to Alzheimer’s disease. Its causes are not really understood yet. What is known is that plaques form from misfolded proteins and that there is an increase in neuronal cell death levels in the brain. However, the plaques don’t necessarily go hand in hand with any symptoms. Dr. Thorsten Müller, Head of the research group Cell Signalling at the Chair of Molecular Biochemistry at Ruhr-Universität Bochum (RUB), suspects other deposits to cause the disease, namely ones that form in the nuclei. He intends to verify this hypothesis using tissue that resembles that of the brain. Rubin, the RUB’s science magazine, published a report on his research.

Typically only one cleavage

In Alzheimer’s patients, the protein is cleaved twice and is thus split into three parts. The middle parts resulting from several cleavages agglutinate and form plaques outside the neuronal cells that are typical of Alzheimer’s disease. The cleaved fragment inside the cell is stable. Its interaction with another protein passes through several interim stages and finally results in the residue migrating into the cell nucleus. There, residues accumulate over time, forming complexes. “In cell culture experiments, this process leads to cell death,” says Müller.

Still, he is cautious to conclude that this is actually how Alzheimer’s disease originates, as there is a big difference between cell culture and living brain.

Organoids resemble small brains

The new method aims at bridging that gap. So-called organoids from stem cells that can be harvested from an adult organism assume the function of a mini brain. The researchers have a number of tricks at their disposal to make the minibrains age artificially. One of the methods is, for example, oxidative stress, which can be induced by adding hydrogen peroxide, or through UV radiation that causes damage to the genetic makeup.

Integrating markers into genetic information

The unique trick employed by the Bochum-based group is to alter the genetic makeup of the stem cells from which the mini brains are formed. “We utilise the Crispr/Cas method for this purpose – so-called genetic scissors,” points out Thorsten Müller. “Unlike many other researchers, we do not simply switch off individual genes; rather, we inject specific components.”

The components in question are markers such as green fluorescent protein (GFP) or marker sequences in different colours. By inserting markers in different colours at, for example, the beginning and the end of a gene sequence that contains the APP blueprint they are able to trace precisely where the protein or its cleaved fragments migrate.

Verification in a living system

In a first step, the researchers have thus been able to verify the findings gathered in cell cultures in a living system. “Using lab-grown tissue that resembles that of the brain, we have now the opportunity to gain new insights in Alzheimer’s research, which is once again in its infancy,” explains Thorsten Müller. Last but not least, a system like that may render animal testing obsolete – the researchers’ last resort when they have no alternatives.

Provided by Ruhr-Universitaet-Bochum